Showing 4991-5000 of 6036 results for "".
- Roche Files for FDA Emergency Use Authorization for SARS-CoV-2 Rapid Antigen Testhttps://modernod.com/news/roche-files-for-fda-emergency-use-authorization-for-sars-cov-2-rapid-antigen-test/2478844/Roche announced it has submitted for FDA Emergency Use Authorization (EUA) for a SARS-CoV-2 Rapid Antigen Test that is designed for use by health care professionals in point-of-care settings with patients experiencing symptoms of COVID-19. The test is designed to help health care professi
- Immunovant Announces Voluntary Pause in Clinical Dosing of IMVT-1401 for Thyroid Eye Diseasehttps://modernod.com/news/immunovant-announces-voluntary-pause-in-clinical-dosing-of-imvt-1401-for-thyroid-eye-disease/2478829/Immunovant announced a voluntary pause of dosing in its ongoing clinical trials of its investigational drug IMVT-1401 for the treatment of Thyroid Eye Disease (TED). The company has become aware of a physiological signal consisting of elevated total cholesterol and LDL levels
- Turn Biotechnologies Expands the Potential of its mRNA Platform by Licensing Unique Artificial Niche Technologyhttps://modernod.com/news/turn-biotechnologies-expands-the-potential-of-its-mrna-platform-by-licensing-unique-artificial-niche-technology/2478826/Turn Biotechnologies announced that it has acquired the global rights for new artificial niche (AN) technology that can be used to restore muscle stem cells damaged by aging. Terms of the deal were not disclosed. The company licensed its AN technology from Stanf
- Inflammasome Therapeutics Says Study Provides Human Data Confirming Potential of Company’s Proprietary Compounds for Prevention of Dry AMDhttps://modernod.com/news/inflammasome-therapeutics-says-study-provides-human-data-confirming-potential-of-companys-proprietary-compounds-for-prevention-of-dry-amd/2478824/Inflammasome Therapeutics reported that data analyses published in the current issue of Proceedings of the National Academy of Sciences (PNAS) confirms that the company’s proprietary compounds hold significant promise in the prevention and treatment of dry age-related macular degeneration
- Prevent Blindness and Bausch + Lomb to Launch Year-Long Video Series to Raise Awareness of Wet AMDhttps://modernod.com/news/prevent-blindness-and-bausch-lomb-to-launch-year-long-video-series-to-raise-awareness-of-wet-amd/2478818/Bausch + Lomb and Prevent Blindness, the nation’s oldest volunteer eye health non-profit organization, announced they are joining together for the sixth consecutive year during AMD Awareness Month to raise awareness of age-related macular degeneration (AMD). The two organizations will launch a ye
- Horizon Therapeutics to Acquire Viela Bio to Grow Rare Disease Medicine Portfoliohttps://modernod.com/news/horizon-therapeutics-to-acquire-viela-bio-to-grow-rare-disease-medicine-portfolio/2478819/Horizon Therapeutics and Viela Bio announced the companies have entered into a definitive agreement under which Horizon will acquire all of the issued and outstanding shares of Viela Bio common stock for $53 per share in cash, which represents a fully diluted equity value of approximately $3.05 b
- Ocutrx Technologies Appoints Bill Link, PhD, as Chairman of the Ocutrx International Scientific Advisory Boardhttps://modernod.com/news/ocutrx-technologies-appoints-bill-link-phd-as-chairman-of-the-ocutrx-international-scientific-advisory-board/2478813/Ocutrx Technologies has announced the appointment of William “Bill” Link, PhD, as the chairman of the Ocutrx International Scientific Advisory Board. The board plays a key role in guiding and prioritizing Ocutrx’s global research and development investment, while serving as the gu
- Influence of Patient Mask Wearing on Ocular Injection-Related Infection Unclearhttps://modernod.com/news/influence-of-patient-mask-wearing-on-ocular-injection-related-infection-unclear/2478807/Pre-pandemic research suggests that mask wearing by clinicians may reduce infectious endophthalmitis in patients receiving ocular injections, and that a no-talking policy can also help. But the influence of mask wearing by patients themselves still remains to be precisely defined, ressearchers sa
- Lilly Teams Up With GSK, Vir to Test Antibody Combination Against COVID-19https://modernod.com/news/lilly-teams-up-with-gsk-vir-to-test-antibody-combination-against-covid-19/2478808/Eli Lilly is expanding the ongoing phase 2 BLAZE-4 trial to include testing a combination of its antibody treatment bamlanivimab with VIR-7831, a dual-action antibody being co-developed by GlaxoSmithKline and Vir Biotechnology, for use in low-risk patients with mild-to-moderate COVID-19, the comp
- Optomed Establishes a Scientific Advisory Boardhttps://modernod.com/news/optomed-establishes-a-scientific-advisory-board/2478806/Optomed announced it is establishing an international scientific advisory board consisting of globally recognized and scientifically merited medical doctors specializing in ophthalmology and neuro-ophthalmology, with advanced experience on artificial intelligence applied to detection of ophthalmi